TSX-V:LXG - TSX Venture Exchange - CA52886L1031 - Common Stock - Currency: CAD
TSX-V:LXG (2/21/2023, 7:00:00 PM)
0.105
-0.03 (-19.23%)
The current stock price of LXG.CA is 0.105 CAD. In the past month the price decreased by -62.5%. In the past year, price decreased by -63.16%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 215.76M | ||
MIR.CA | MEDMIRA INC | N/A | 60.66M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 40.88M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 39.74M | ||
NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 32.83M | ||
ASG.CA | AURORA SPINE CORP | N/A | 23.55M | ||
MDX.CA | MEDX HEALTH CORP | N/A | 21.44M | ||
VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 19.57M | ||
CNVI.CA | CONAVI MEDICAL CORP | N/A | 17.70M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 9.09M | ||
VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 439.40K |
Lexagene Holdings Inc. develops biomedical devices. The company is headquartered in Beverly, Massachusetts and currently employs 33 full-time employees. The company went IPO on 2007-08-28. The firm is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The firm's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.
LEXAGENE HOLDINGS INC
500 Cummings Ctr., Suite 4550
Beverly MASSACHUSETTS 01915 US
CEO: John F. Regan
Employees: 33
Phone: 18002151824.0
The current stock price of LXG.CA is 0.105 CAD. The price decreased by -19.23% in the last trading session.
The exchange symbol of LEXAGENE HOLDINGS INC is LXG and it is listed on the TSX Venture Exchange exchange.
LXG.CA stock is listed on the TSX Venture Exchange exchange.
9 analysts have analysed LXG.CA and the average price target is 0.51 CAD. This implies a price increase of 385.71% is expected in the next year compared to the current price of 0.105. Check the LEXAGENE HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
LEXAGENE HOLDINGS INC (LXG.CA) has a market capitalization of 14.77M CAD. This makes LXG.CA a Nano Cap stock.
LEXAGENE HOLDINGS INC (LXG.CA) currently has 33 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LXG.CA does not pay a dividend.
LEXAGENE HOLDINGS INC (LXG.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.18).
ChartMill assigns a fundamental rating of 1 / 10 to LXG.CA. Both the profitability and financial health of LXG.CA have multiple concerns.
Over the last trailing twelve months LXG.CA reported a non-GAAP Earnings per Share(EPS) of -0.18. The EPS decreased by -45.78% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | 0.44 |
ChartMill assigns a Buy % Consensus number of 84% to LXG.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.